Belpointe Asset Management LLC Sells 8,294 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Belpointe Asset Management LLC sold 8,294 shares of GE HealthCare Technologies, reducing its holdings by 46.2% during the second quarter, leaving it with a total of 9,673 shares valued at $716,000.
• GE HealthCare Technologies reported $1.06 earnings per share (EPS) for the last quarter, surpassing the consensus estimate of $0.91, and the company had revenue of $5 billion compared to expectations of $4.96 billion.
• The company announced a quarterly dividend of $0.035 per share to be paid on November 14th, with an annualized dividend yield of 0.2% and a payout ratio of 2.87%.

Belpointe Asset Management LLC lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 46.2% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 9,673 shares of the company's stock after selling 8,294 shares during the period. Belpointe Asset Management LLC's holdings in GE HealthCare Technologies were worth $716,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of GEHC. NBC Securities Inc. bought a new position in GE HealthCare Technologies in the 1st quarter worth $43,000. Wedmont Private Capital boosted its holdings in GE HealthCare Technologies by 7.0% in the 1st quarter. Wedmont Private Capital now owns 6,068 shares of the company's stock worth $490,000 after buying an additional 395 shares during the period. UMB Bank n.a. boosted its holdings in GE HealthCare Technologies by 17.1% in the 1st quarter. UMB Bank n.a. now owns 2,180 shares of the company's stock worth $176,000 after buying an additional 318 shares during the period. Miracle Mile Advisors LLC boosted its holdings in GE HealthCare Technologies by 50.2% in the 1st quarter. Miracle Mile Advisors LLC now owns 4,621 shares of the company's stock worth $373,000 after buying an additional 1,545 shares during the period. Finally, Park Avenue Securities LLC boosted its holdings in GE HealthCare Technologies by 32.3% in the 1st quarter. Park Avenue Securities LLC now owns 5,887 shares of the company's stock worth $475,000 after buying an additional 1,437 shares during the period. Institutional investors own 82.06% of the company's stock.

GE HealthCare Technologies Stock Up 0.9%

Shares of NASDAQ GEHC opened at $75.13 on Thursday. The firm's 50-day moving average price is $74.22 and its 200-day moving average price is $72.47. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $34.30 billion, a price-to-earnings ratio of 15.40, a P/E/G ratio of 2.85 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business's revenue was up 3.5% compared to the same quarter last year. During the same period in the prior year, the company earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies's dividend payout ratio is 2.87%.

Analysts Set New Price Targets

Several analysts have commented on the stock. Wall Street Zen cut shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research note on Saturday, September 20th. Weiss Ratings reiterated a "hold (c)" rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Citigroup cut shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and decreased their price target for the stock from $93.00 to $83.00 in a research note on Tuesday. Finally, Zacks Research cut shares of GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 29th. Six equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $85.78.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.